FIGO consensus guidelines on intrapartum fetal monitoring: Physiology of fetal oxygenation and the main goals of intrapartum fetal monitoring
Year: 2015
Type: article
Abstract: This article focuses on the major aspects of the physiology of oxygen supply to the fetus and the main goals of intrapartum fetal monitoring: (1) timely identification of fetuses that are being inadequately oxygenated, to enable appropriate action before the occurrence of injury; and (2) reassurance on adequate fetal oxygenation to avoid unnecessary obstetric interventions. It should be emphasized that to avoid adverse outcome, fetal surveillance requires a timely clinical response and the ready availability of both adequate equipment and trained staff in intrapartum care. All human cells require oxygen and glucose to maintain aerobic metabolism, their main source of energy production. Glucose can usually be stored and mobilized when needed, but total lack of oxygen supply for just a few minutes is enough to place the cells at risk. During fetal life, oxygen supply is entirely dependent on maternal respiration and circulation, placental perfusion, gas exchange across the placenta, and umbilical and fetal circulations. Complications occurring at any of these levels may result in decreased oxygen concentration in fetal arterial blood (hypoxemia) and ultimately in the tissues (hypoxia). Some degree of hypoxemia occurs in almost all fetuses during labor, but it is the intensity, duration, and repetitive nature of the event, together with the individual variation in the capacity of each fetus to cope with the situation, that will determine the severity of the resulting hypoxia. Difficulties in carbon dioxide (CO2) elimination across the placenta will result in elevated CO2 concentrations, and this gas will combine with water to increase carbonic acid (H2CO3) concentration, a phenomenon called respiratory acidemia. The process is quickly reversible with re-establishment of placental gas exchange, as CO2 diffuses rapidly across the placenta. There is no evidence of injury from isolated respiratory acidemia. When hypoxia occurs, cellular energy production can still be maintained for a limited time by anaerobic metabolism, but this process produces 19 times less energy and results in the accumulation of lactic acid inside the cell, and its dispersion to the extracellular fluid and fetal circulation. The increased concentration of hydrogen ions of intracellular origin in the fetal circulation is called metabolic acidemia, but it closely parallels hydrogen ion concentration in the tissues, so the term metabolic acidosis is frequently used as a synonym. The hydrogen ions of lactic acid are transferred very slowly across the placenta, but they are buffered by circulating bases, comprised mainly of bicarbonate, hemoglobin, and plasma proteins. The depletion of these buffering agents (increasing base deficit, or base excess in negative numbers) indicates the growing inability to neutralize hydrogen ions, and their continued production will ultimately lead to the disruption of cellular enzyme systems and to tissue injury. As oxygen concentration in the tissues cannot in practice be quantified, the occurrence of fetal hypoxia can only be assessed by the documentation of metabolic acidosis. Metabolic acidosis can be evaluated by sampling arterial and venous blood from the umbilical cord immediately after birth (see Appendix 1 for a detailed description of the method), measuring pH and partial pressure of carbon dioxide (pCO2), and the derived bicarbonate (HCO3-) and base deficit (BD) values. Base deficit in the extracellular fluid (BDecf), as calculated from umbilical cord blood parameters using the Siggaard-Andersen formula [1,2], is believed by some experts to be the best representative of hydrogen ion concentration of metabolic origin in the different fetal compartments, but the slightly higher BDblood, as calculated by blood gas analyzers can also be used. It should however be noted that different blood gas analyzers may use different algorithms to calculate BDblood [3]. Metabolic acidosis is defined as the measurement in umbilical artery blood of a pH value below 7.00 and a BD in excess of 12 mmol/L [4–6]. However, there is already an association with adverse short-term newborn outcome when pH values are below 7.05 and BDecf values are above 10 mmol/L [7]. Alternatively, umbilical artery blood lactate concentration may be used to quantify metabolic acidosis, and values exceeding 10 mmol/L have been strongly associated with adverse short-term newborn outcome [8]. However, analyzing devices are often calibrated differently or measure lactate concentrations in different blood compartments, therefore reference values may vary according to the device [9]. Blood gas and lactate analysis in the umbilical cord or in the newborn circulation during the first minutes of life is currently the only way of quantifying objectively the occurrence of hypoxia/acidosis just prior to birth. Umbilical blood sampling is innocuous to the newborn and relatively inexpensive. The resulting information provides useful and immediate feedback to the labor ward staff and can enhance the team's experience with intrapartum monitoring. Umbilical cord blood analysis is also frequently considered important evidence in medico-legal claims. Local guidelines should determine the clinical situations in which umbilical blood analysis will be performed, but if the technology and resources are available, it is recommended in all cases of suspected fetal hypoxia/acidosis and/or low Apgar scores. It should be noted that the presence of metabolic acidosis does not exclude other contributory factors in the causation of neonatal depression and/or subsequent handicap (e.g. prematurity, birth trauma, infection, meconium aspiration, certain congenital anomalies, pre-existing lesions, neonatal hypoxia). Similarly, the absence of metabolic acidosis at birth does not exclude the occurrence of hypoxia/acidosis during pregnancy or earlier in labor. The Apgar score reflects the pulmonary, cardiovascular, and neurological functions of the newborn, and is depressed when hypoxia is sufficiently intense and prolonged to affect these systems. The 1-minute Apgar score is a crucial parameter to decide the start of newborn resuscitation [10], but has a relatively low association with intrapartum hypoxia/acidosis. Low Apgar scores at both 1 and 5 minutes are expected when severe intrapartum hypoxia/acidosis occurs, but the 5-minute Apgar has a stronger association with short- and long-term neurological outcome and neonatal death [11–13]. However, it is important to remember that Apgar scores are not affected by minor degrees of fetal hypoxia, score assignment is subject to some interobserver disagreement [14], and values can be low due to nonhypoxic causes, such as prematurity, birth trauma, infection, meconium aspiration, certain congenital anomalies, pre-existing lesions, medication administered to the mother, and early neonatal interventions such as vigorous endotracheal aspiration [15]. Low intracellular pH and inadequate energy production caused by hypoxia/acidosis have the potential to compromise cell function and to cause cell death. However, the vast majority of fetuses born with metabolic acidosis, with or without decreased Apgar scores, recover quickly and will not incur any short- or long-term complications [4,13,16,17]. In only a few cases will fetal hypoxia/acidosis be of sufficient intensity and duration to cause malfunction of important organs and systems, and thereby put the newborn at risk of death or long-term morbidity. Short-term neurological dysfunction caused by intrapartum hypoxia/acidosis is called hypoxic-ischemic encephalopathy (HIE), and this diagnosis requires the confirmation of metabolic acidosis, low Apgar scores, early imaging evidence of cerebral edema, and the appearance of changes in muscular tone, sucking movements, seizures, or coma in the first 48 hours of life [18,19]. The Sarnat classification [18] divides HIE into three grades, which in a simplified version can be described as: Grade 1: no seizures present—the vast majority of newborns do not develop major long-term neurological sequelae; Grade 2: seizures—associated with a 20%−30% risk of death or major neurological sequelae; Grade 3: coma—the majority of newborns die or develop long-term neurological sequelae [19,20]. Importantly, there are other nonhypoxic causes for neonatal encephalopathy, and the hypoxic-ischemic nature of this entity needs to be confirmed by the documentation of metabolic acidosis in the umbilical artery or in the newborn circulation during the first minutes of life [21]. HIE may also be accompanied by dysfunction of the cardiovascular, gastrointestinal, hematological, pulmonary, or renal systems. Cerebral palsy of the spastic quadriplegic or dyskinetic type is the long-term neurological complication that is more commonly associated with intrapartum hypoxia/acidosis at term, but in high-resource countries only 10%−20% of cerebral palsy cases are caused by birth asphyxia [22,23]. Infection, congenital diseases, metabolic diseases, coagulation disorders, antepartum and postnatal hypoxia, and the complications associated with birth trauma and prematurity constitute the majority of causal situations. It may also be linked to a combination of antepartum and intrapartum events. To implicate intrapartum hypoxia/acidosis as the cause of cerebral palsy in term infants there is a need to document the joint occurrence of metabolic acidosis, low 1- and 5-minute Apgar scores, early onset grade 2 or 3 HIE, early imaging studies showing evidence of an acute and nonfocal cerebral anomaly, the development of spastic quadriplegic or dyskinetic types of cerebral palsy, and to exclude other identifiable etiologies (birth trauma, coagulation disorders, infection, and genetic disorders) [6,24]. While avoiding adverse fetal outcome related to hypoxia/acidosis is the main objective of intrapartum fetal monitoring, it is equally important that it does not result in unnecessary obstetric intervention, as some of these procedures, such as instrumental vaginal delivery and cesarean delivery, are associated with increased maternal and fetal risks [25–29]. Contractions compress the maternal blood vessels running inside the myometrium, decreasing placental perfusion [30], and this can result in a temporary reduction of maternal–fetal gas exchange. If during contractions the umbilical cord is compressed between fetal parts, or between fetal parts and the uterine wall, this will result in interference with blood circulation. The frequency, duration, and intensity of uterine contractions are key determinants of the magnitude and effects of these disturbances. The interval between contractions is of particular importance for re-establishment of fetal oxygenation. There are data to suggest that in spontaneous labor it takes up to 90 seconds after a contraction for fetal oxygenation to be restored [31], while in oxytocin-augmented labors this recovery period averages 138 seconds [32]. Excessive uterine activity (see [33] for a definition) is often responsible for decreased fetal oxygenation, and where possible, should be avoided irrespective of fetal heart rate changes [34]. Whether spontaneous or iatrogenic in nature, excessive uterine activity can usually be reversed by reducing or stopping oxytocin infusion and/or starting acute tocolysis with beta-adrenergic agonists (salbutamol, terbutaline, ritodrine) [35], atosiban [36], or nitroglycerine [37]. Other less frequent intrapartum complications can also affect fetal oxygenation. Some of these are of maternal origin, such as the occurrence of acute respiratory distress, cardiorespiratory arrest following amniotic fluid embolism or pulmonary thromboembolism, or sudden maternal hypotension that may occur after epidural or spinal analgesia [38]. Major placental abruption and uterine rupture will also severely impact fetal oxygenation, the latter due to acute maternal blood loss and/or to the disruption of placental blood supply. Several mechanical complications of delivery may cause compression of the umbilical cord and/or parts of the fetal circulation, such as umbilical cord prolapse, shoulder dystocia, and retention of the after-coming head in a breech delivery. It is also important to note that maternal supine position can lead to aortocaval compression by the pregnant uterus, resulting in reduced placental gas exchange and temporary hypoxemia. Finally, the rare occurrence of fetal hemorrhage, associated with ruptured vasa previa or fetal–maternal hemorrhage, will reduce the oxygen-carrying capacity of the fetal circulation. All of these complications require specific interventions for their resolution, to tackle the underlying cause and to determine the timing of delivery, with the objective of avoiding prolonged fetal hypoxia/acidosis, as well as unnecessary obstetric intervention. While the specific management of each of these situations is beyond the scope of this document, the general principles involved in the clinical reaction to the fetal heart rate patterns associated with these events are included in the cardiotocography chapter that forms part of FIGO's guidelines on intrapartum fetal monitoring [33]. The authors have no conflicts of interest. Sampling of umbilical arterial and venous blood shortly after delivery is needed to document objectively the occurrence of fetal hypoxia/acidosis. Clamping of the cord is not necessary before vessels are sampled, but umbilical blood gas concentrations change quickly after birth, so this needs to be performed as soon as possible [1,2]. Even if the cord is doubly clamped, sampling of vessels should be performed as soon as possible and preferably within 15 minutes, as blood gas and lactate values change significantly over time [3,4]. Blood should be drawn, introducing as little air as possible, into two different 1- or 2-mL pre-heparinized syringes (if pre-heparinized syringes are not available, a small quantity of heparin can be drawn into normal syringes, and the excess heparin expelled before blood sampling). After blood is drawn, existing air bubbles should be removed from the syringes, these should be capped, rolled between the fingers to mix blood with heparin, and blood gas analysis should be performed in a calibrated apparatus within the next 30 minutes [3]. Umbilical arterial blood reflects the fetal acid-base status better than venous blood. However, it is important to obtain blood from both artery and vein to assure that a valid arterial sample is present. Sampling of the wrong vessel is not uncommon, particularly when the needle crosses the artery to pierce the vein, and this can also result in mixed sampling. Arterial pH is lower than that of the vein, and when the difference in pH between the two blood samples is less than 0.02 and the difference in pCO2 is less than 5 mm Hg or 0.7 kPa (kilopascal), then the samples are most likely mixed or were obtained from the same vessel [4]. In addition, a pCO2 less than 22 mm Hg or 2.9 kPa is almost impossible to achieve in the umbilical artery, so such a value indicates likely contamination from the umbilical vein or from air [5]. Median umbilical artery pH in deliveries after 36 weeks of gestation is 7.25 (5th percentile 7.06; 95th percentile 7.37), median arterial BDecf 2.8 mmol/L (5th percentile −1.8; 95th percentile 10.0) [4]. Mean arterial BDblood in a similar population was 5.6 mmol/L (5th percentile 0.28; 95th percentile 11.48) [6]. When placental gas exchange is preserved, there is slow transfer of hydrogen ions in both directions, so maternal hyperventilation may result in an increase in fetal pH and likewise maternal acidemia will slowly result in fetal acidemia. When gas exchange across the placenta is compromised or when there is significant umbilical cord occlusion, both increased carbon dioxide and decreased oxygen concentrations may occur in the fetus, and thus an acidemia of mixed respiratory and metabolic origin is documented. However, the metabolic component, reflected in the base deficit is the one with the greatest potential for harm, as it indicates decreased cellular oxygen concentration and reduced energy production. References [1] Armstrong L, Stenson B. Effect of delayed sampling on umbilical cord arterial and venous lactate and blood gases in clamped and unclamped vessels. Arch Dis Child Fetal Neonatal Ed 2006;91(5):F342–5. [2] Wiberg N, Kallen K, Olofsson P. Delayed umbilical cord clamping at birth has effects on arterial and venous blood gases and lactate concentrations. BJOG 2008;115(6):697–703. [3] ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 348, November 2006: Umbilical cord blood gas and acid-base analysis. Obstet Gynecol 2006;108(5):1319–22. [4] White CR, Mok, T, Doherty DA, Henderson JJ, Newnham JP, Pennell CE. The effect of time, temperature and storage device on umbilical cord blood gas and lactate measurement: a randomized controlled trial. J Mater Fetal Neonat Med 2012;25(6):587–94. [5] Kro GA, Yli B, Rasmussen S, Noren H, Amer-Wahlin I, Saugstad OD, et al. A new tool for the validation of umbilical cord acid-base data. BJOG 2010;117(12):1544–52. [6] Victory R, Penava D, da Silva O, Natale R, Richardson B. Umbilical cord pH and base excess values in relation to adverse outcome events for infants delivering at term. Am J Obstet Gynecol 2004;191(6):2021–8.
Authors: Diogo Ayres‐de‐Campos, Sabaratnam Arulkumaran, FIGO Intrapartum Fetal Monitoring Expert Consensus Panel
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,480
OpenAlex ID: W1910114270
